Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packard

Showing results (141-150 of 1,753) with videos related to

Pageof 176
Sort By:
Current Opinion in Cardiology|May 7, 2009
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic targetChris J Packard
Applied Optics|January 15, 2010
A Bonding Material Useful in the 2-14 microm Spectral RangeR D Packard
Journal of Theoretical Biology|November 19, 2008
On the use of logarithmic transformations in allometric analysesGary C Packard
Expert Review of Clinical Pharmacology|November 25, 2011
Optimizing lipid-lowering therapy in the prevention of coronary heart diseaseChris J Packard
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|May 22, 2013
Fitting statistical models in bivariate allometry: scaling metabolic rate to body mass in mustelid carnivoresGary C Packard
Circulation|November 16, 2020
Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"Chris J Packard
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2020
SNMMI Leadership Update: Research-The Key to Nuclear Medicine's Past and FutureAlan B Packard
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2020
SNMMI Leadership Update: Improving Radionuclide AvailabilityAlan B Packard
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|March 27, 2014
Multiplicative by nature: Logarithmic transformation in allometryGary C Packard
Headache|November 1, 1987
Propranolol ... not guiltyR C Packard
Pageof 176

Showing results (141-150 of 1,753) with videos related to

Sort By:
Pageof 176
Current Opinion in Cardiology|May 7, 2009
Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic targetChris J Packard
Applied Optics|January 15, 2010
A Bonding Material Useful in the 2-14 microm Spectral RangeR D Packard
Journal of Theoretical Biology|November 19, 2008
On the use of logarithmic transformations in allometric analysesGary C Packard
Expert Review of Clinical Pharmacology|November 25, 2011
Optimizing lipid-lowering therapy in the prevention of coronary heart diseaseChris J Packard
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|May 22, 2013
Fitting statistical models in bivariate allometry: scaling metabolic rate to body mass in mustelid carnivoresGary C Packard
Circulation|November 16, 2020
Letter by Packard Regarding Article, "Peripheral Artery Disease and Venous Thromboembolic Events After Acute Coronary Syndrome: Role of Lipoprotein(a) and Modification by Alirocumab: Prespecified Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial"Chris J Packard
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 3, 2020
SNMMI Leadership Update: Research-The Key to Nuclear Medicine's Past and FutureAlan B Packard
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 18, 2020
SNMMI Leadership Update: Improving Radionuclide AvailabilityAlan B Packard
Journal of Experimental Zoology. Part B, Molecular and Developmental Evolution|March 27, 2014
Multiplicative by nature: Logarithmic transformation in allometryGary C Packard
Headache|November 1, 1987
Propranolol ... not guiltyR C Packard
Pageof 176